Original article by Julia Medew
The Age – Page: 3 : 23-Jul-14

Experts on acquired immunodeficiency syndrome (AIDS) on 22 July 2014 heard from Aarhus University Hospital’s Ole Sogaard at the 20th International AIDS conference in Melbourne. He reported good results in using the romidepsin cancer drug to lure the human immunodeficiency virus (HIV) into a patient’s bloodstream. Once this has occurred, the immune system can attack the HIV cells, if aided by the Vacc-4x experimental vaccine

CORPORATES
UNIVERSITY OF AARHUS|UNIVERSITY OF CALIFORNIA|BIOSANTECH SA